Mark Greenwald

Mark Greenwald

Professor and Associate Chair-Research

mgreen@med.wayne.edu

Mark Greenwald

Division

 Substance Abuse Research Division

Research Interests

Pharmacological, environmental and individual difference determinants of drug-seeking/use behavior (primary endpoint) and neural processes (measured with in vivo imaging methods) related to these behaviors.

Disease/Disorder

Opioid, cocaine, marijuana, nicotine, and alcohol use disorders.

Species

Human

Methods

PET (opioid and dopamine), 1H spectroscopy, fMRI and EEG.

Key Collaborators

Leslie Lundahl, David Ledgerwood and Cynthia Arfken (substance use disorders, HIV/AIDS); Jeffrey Stanley (1H spectroscopy); Vaibhav Diwadkar (fMRI, learning/memory); Sylvie Naar-King and Paul Burghardt (stress, physical activity and obesity); Terrance Albrecht, Ann Schwartz and Jennifer Beebe-Dimmer (KCI: chemotherapy-induced peripheral neuropathy); Timothy Roehrs (Henry Ford: EEG, sleep, pain); Margit Burmeister (Univ. of Michigan: pharmacogenetics).

Publications

PubMed Search (past 5 years).

← Return to listing